FDA Approves New Medication for Acute Pain

Image of a human body, with acute pain in the neck illustrated with a radiating yellow/red burst

The U.S. Food and Drug Administration has approved Vertex Pharmaceutical’s Journavx (suzetrigine), a new type of prescription pain medication for adults to treat moderate to severe acute pain.

Bivigam, Gamunex-C and Panzyga Lots Withdrawn

Specific lots of intravenous immune globulin (IVIG) and subcutaneous IG  (SCIG) have been voluntarily withdrawn by the manufacturers due to a higher rate of allergic/hypersensitivity type reactions, some of which were considered medically significant.